ABCSG 12 Summary

Tamoxifen compared to anastrozole, single or in combination with zoledronat in pre-menopausal patients with breast cancer stadium I and II and hormone-receptor-positive tumor.

Recruiting period: 06/1999 – 05/2006
Coordinating investigator: Gnant, Michael; Vienna
Sample size: 1.250 *)
(Click to enlarge)

*) increased to 1.800 patients, Amendment 5

Link for studyteam-members only

Further information about this trial

Access to these informations only with keyword. If required, please ask the responsible project manager.